Mira A. M. Behnam

发表

Thiazolidinone-peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture.

Ralf Bartenschlager, Christoph Nitsche, R. Bartenschlager, 2013, Journal of medicinal chemistry.

Retro peptide-hybrids as selective inhibitors of the Dengue virus NS2B-NS3 protease.

C. Steuer, C. Klein, Christoph Nitsche, 2012, Antiviral research.

A New Class of Dengue and West Nile Virus Protease Inhibitors With Submicromolar Activity in Reporter Gene DENV-2 Protease and Viral Replication Assays.

C. Klein, D. Graf, Mira A. M. Behnam, 2020, Journal of medicinal chemistry.

Efficiency Improvements and Discovery of New Substrates for a SARS-CoV-2 Main Protease FRET Assay

C. Klein, Mira A. M. Behnam, Nikos Kühl, 2021, bioRxiv.

On track to tackle dengue: History and future of NS4B ligands.

C. Klein, Mira A. M. Behnam, 2021, Cell host & microbe.

The Medicinal Chemistry of Dengue Virus.

Christoph Nitsche, Veaceslav Boldescu, V. Boldescu, 2016, Journal of medicinal chemistry.

Phenylglycine racemization in Fmoc-based solid-phase peptide synthesis: Stereochemical stability is achieved by choice of reaction conditions

C. Klein, Mira A. M. Behnam, Chen Liang, 2017 .

Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond

N. Vasilakis, V. Boldescu, C. Klein, 2017, Nature Reviews Drug Discovery.

Discovery of Nanomolar Dengue and West Nile Virus Protease Inhibitors Containing a 4-Benzyloxyphenylglycine Residue.

R. Bartenschlager, C. Klein, D. Graf, 2015, Journal of medicinal chemistry.

Conformational selection in the flaviviral NS2B-NS3 protease.

C. Klein, Mira A. M. Behnam, 2020, Biochimie.

2-[(1,3-Dihydro-2H-isoindol-2-yl)methyl]melatonin – a novel MT2-selective melatonin receptor antagonist

P. Witt-Enderby, Christian Markl, Mira A. M. Behnam, 2011 .

C-terminal residue optimization and fragment merging: discovery of a potent Peptide-hybrid inhibitor of dengue protease.

C. Klein, Christoph Nitsche, Mira A. M. Behnam, 2014, ACS medicinal chemistry letters.

Solid Phase Synthesis of C-Terminal Boronic Acid Peptides.

C. Klein, Mira A. M. Behnam, T. Sundermann, 2016, Organic letters.

Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2

Mira A. M. Behnam, 2021, Biochimie.

Inhibitor potency and assay conditions: A case study on SARS-CoV-2 main protease

C. Klein, Mira A. M. Behnam, 2021, Proceedings of the National Academy of Sciences of the United States of America.

Dual inhibitors of the dengue and West Nile virus NS2B-NS3 proteases: Synthesis, biological evaluation and docking studies of novel peptide-hybrids.

C. Klein, Christoph Nitsche, Mira A. M. Behnam, 2015, Bioorganic & medicinal chemistry.